BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33087697)

  • 1. Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers.
    Bradley SD; Talukder AH; Lai I; Davis R; Alvarez H; Tiriac H; Zhang M; Chiu Y; Melendez B; Jackson KR; Katailiha A; Sonnemann HM; Li F; Kang Y; Qiao N; Pan BF; Lorenzi PL; Hurd M; Mittendorf EA; Peterson CB; Javle M; Bristow C; Kim M; Tuveson DA; Hawke D; Kopetz S; Wolff RA; Hwu P; Maitra A; Roszik J; Yee C; Lizée G
    Nat Commun; 2020 Oct; 11(1):5332. PubMed ID: 33087697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes.
    Peiper M; Goedegebuure PS; Linehan DC; Ganguly E; Douville CC; Eberlein TJ
    Eur J Immunol; 1997 May; 27(5):1115-23. PubMed ID: 9174600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
    Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W
    Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
    Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tsunoda T; Nakatsuru S; Nakagawa H; Nakamura Y; Baba H; Nishimura Y
    Clin Cancer Res; 2008 Oct; 14(20):6487-95. PubMed ID: 18927288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of a shared pancreatic cancer antigen recognized by an HLA-A*2601-restricted cytotoxic T-lymphocyte clone.
    Kashiwagi K; Ikeda H; Hirohashi Y; Yamamoto M; Idenoue S; Hirai I; Kamiguchi K; Tamura Y; Torigoe T; Wada Y; Hirata K; Sato N
    Pancreas; 2003 May; 26(4):e81-8. PubMed ID: 12717278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
    Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
    Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer.
    Linehan DC; Goedegebuure PS; Peoples GE; Rogers SO; Eberlein TJ
    J Immunol; 1995 Nov; 155(9):4486-91. PubMed ID: 7594611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma.
    Raj D; Nikolaidi M; Garces I; Lorizio D; Castro NM; Caiafa SG; Moore K; Brown NF; Kocher HM; Duan X; Nelson BH; Lemoine NR; Marshall JF
    Clin Cancer Res; 2021 Mar; 27(5):1538-1552. PubMed ID: 33479048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis.
    Yoshitake Y; Nakatsura T; Monji M; Senju S; Matsuyoshi H; Tsukamoto H; Hosaka S; Komori H; Fukuma D; Ikuta Y; Katagiri T; Furukawa Y; Ito H; Shinohara M; Nakamura Y; Nishimura Y
    Clin Cancer Res; 2004 Oct; 10(19):6437-48. PubMed ID: 15475430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zebularine Treatment Induces MAGE-A11 Expression and Improves CTL Cytotoxicity Using a Novel Identified HLA-A2-restricted MAGE-A11 Peptide.
    Zhang J; Sang M; Gu L; Liu F; Li W; Yin D; Wu Y; Liu S; Huang W; Shan B
    J Immunother; 2017; 40(6):211-220. PubMed ID: 28486273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes.
    de Koning W; Latifi D; Li Y; van Eijck CHJ; Stubbs AP; Mustafa DAM
    Front Immunol; 2021; 12():649061. PubMed ID: 33986743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC.
    Xu YF; Lu Y; Cheng H; Jiang J; Xu J; Long J; Liu L; Ni Q; Liu C; Yu XJ
    Curr Mol Med; 2015; 15(4):360-7. PubMed ID: 25829020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful generation of sperm protein 17 (Sp17)-specific cytotoxic T lymphocytes from normal donors: implication for tumour-specific adoptive immunotherapy following allogeneic stem cell transplantation for Sp17-positive multiple myeloma.
    Chiriva-Internati M; Wang Z; Salati E; Wroblewski D; Lim SH
    Scand J Immunol; 2002 Oct; 56(4):429-33. PubMed ID: 12234264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HLA-A*0201- and A*2402-restricted epitopes of mucin 5AC expressed in advanced pancreatic cancer.
    Yamazoe S; Tanaka H; Iwauchi T; Yoshii M; Ito G; Amano R; Yamada N; Sawada T; Ohira M; Hirakawa K
    Pancreas; 2011 Aug; 40(6):896-904. PubMed ID: 21697763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.
    Jerome KR; Domenech N; Finn OJ
    J Immunol; 1993 Aug; 151(3):1654-62. PubMed ID: 8393050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies.
    Kim VM; Blair AB; Lauer P; Foley K; Che X; Soares K; Xia T; Muth ST; Kleponis J; Armstrong TD; Wolfgang CL; Jaffee EM; Brockstedt D; Zheng L
    J Immunother Cancer; 2019 May; 7(1):132. PubMed ID: 31113479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.
    Suda T; Tsunoda T; Daigo Y; Nakamura Y; Tahara H
    Cancer Sci; 2007 Nov; 98(11):1803-8. PubMed ID: 17784873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel HLA-A(*)0201-restricted CTL epitopes from Pokemon.
    Yuan B; Zhao L; Xian R; Zhao G
    Cell Immunol; 2012; 274(1-2):54-60. PubMed ID: 22405859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity.
    Park J; Talukder AH; Lim SA; Kim K; Pan K; Melendez B; Bradley SD; Jackson KR; Khalili JS; Wang J; Creasy C; Pan BF; Woodman SE; Bernatchez C; Hawke D; Hwu P; Lee KM; Roszik J; Lizée G; Yee C
    Cancer Immunol Res; 2017 Aug; 5(8):618-629. PubMed ID: 28630054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered T cells for pancreatic cancer treatment.
    Katari UL; Keirnan JM; Worth AC; Hodges SE; Leen AM; Fisher WE; Vera JF
    HPB (Oxford); 2011 Sep; 13(9):643-50. PubMed ID: 21843265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.